miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1
- Type
- Retraction
- Notice date
- 3/14/2023 0:00
- Journal
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.biopha.2023.114720
- Original paper DOI
- 10.1016/j.biopha.2018.07.024
Reasons
- Author Unresponsive
- Duplication of/in Image
- Investigation by Third Party
- Original Data and/or Images not Provided and/or not Available
- Unreliable Data
- Unreliable Results and/or Conclusions
- Upgrade/Update of Prior Notice(s)